Posted in | News | Display

TeraXion Introduces New Dispersion Compensation Products at OFC/NFOEC

TeraXion Inc., a technology leader in performance-defining OEM products used for the generation and conditioning of light signals in mission-critical applications in the Telecom, Defense & Aerospace and Industrial markets, will display a series of innovative new dispersion products at the 2007 Optical Fiber Conference, OFC/NFOEC in the Anaheim, California Convention Center on March 27-29 .

With two additions in its fixed dispersion product portfolio and a third one enhancing the tunable product suite, TeraXion expands the set of solutions of its well-established ClearSpectrum™ product line.

  • ClearSpectrum™ DCMX-400 km. Extends the level of compensation from 200 km up to 400 km with insertion loss below 5 dB. This new series complements TeraXion's portfolio of DCMX which compensates from 20 km up to 200 km with a maximum insertion loss of 3 dB.
  • ClearSpectrum™ DCMX-40G Ready. These new modules are designed with a sufficient bandwidth to allow their use for in-line applications in 40G ready networks. The standard 20 to 100 km modules are available with insertion loss below 3 dB.
  • ClearSpectrum™ TDCM-low PMD. This new option on the TDCM TuneX guarantees a PMD less than 0.3 ps over the tuning range for TDCMs designed for the 10 Gb/s or the 40 Gb/s market. Through innovative engineering, TeraXion significantly reduced this critical parameter for 40G systems.

    These new ClearSpectrum™-dispersion compensators will be on display at the 2007 OFC/NFOEC exhibition, TeraXion booth # 3157, on March 27-29, in Anaheim, California.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.